Pediatrics Group Calls for Metric-Only Dosing of
Liquid Medications

A teaspoon of sugar might help the medicine go down, but it shouldn’t be used to measure liquid drugs, according to a new policy statement from the American Academy of Pediatrics. Find out how pharmacists can help educate parents and caregivers in the correct way to dose children with liquid medications.

Routine Post-Fracture Bisphosphonates: Cost-Prohibitive for Older Women

Hip fractures can be devastating injuries for older patients, and routine bisphosphonate treatment potentially could prevent about a fourth of them. Yet, here’s why a cost-benefit analysis recommends against routine bisphosphonate treatment of women over age 65, even after they suffer a distal radius fracture.

Statins are routinely prescribed to patients with a history of heart disease and stroke. It’s the other group—those with high cholesterol but no cardiovascular disease—who often ask pharmacists whether they should be on statins. A new article provides some tips on answering those questions.

The Name Game: Controversy Continues on
Biosimilar Naming Policy

Biosimilars are just that—similar but not identical to existing drugs. As a result, a heated debate has emerged on the naming policy for them and whether they should share a name with an existing similar product. Find out how major pharmacy groups come down on the question.